CellSeed Inc. (7776.T)
JPY 535.0
(-1.47%)
JPY 535.0
(-1.47%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -697.77 Million JPY | 6.11% |
| 2022 | -743.21 Million JPY | 13.99% |
| 2021 | -864.1 Million JPY | -20.09% |
| 2020 | -719.52 Million JPY | 12.89% |
| 2019 | -825.97 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -231.57 Million JPY | 0.44% |
| 2024 Q1 | -232.59 Million JPY | -92.58% |
| 2023 Q2 | -177.51 Million JPY | 2.3% |
| 2023 Q4 | -120.77 Million JPY | 44.54% |
| 2023 FY | -697.77 Million JPY | 6.11% |
| 2023 Q1 | -181.7 Million JPY | -1.65% |
| 2023 Q3 | -217.78 Million JPY | -22.68% |
| 2022 Q3 | -215.62 Million JPY | 0.0% |
| 2022 FY | -743.21 Million JPY | 13.99% |
| 2022 Q4 | -178.74 Million JPY | 17.1% |
| 2021 FY | -864.1 Million JPY | -20.09% |
| 2020 FY | -719.52 Million JPY | 12.89% |
| 2019 FY | -825.97 Million JPY | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 216.915% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -40.435% |
| GNI Group Ltd. | 13.1 Billion JPY | 105.323% |
| Linical Co., Ltd. | 725.72 Million JPY | 196.149% |
| Trans Genic Inc. | 89.43 Million JPY | 880.196% |
| MEDINET Co., Ltd. | -1.42 Billion JPY | 51.066% |
| Soiken Holdings Inc. | -610 Million JPY | -14.388% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | 9.701% |
| AnGes, Inc. | -11.96 Billion JPY | 94.169% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | 37.743% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 92.675% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 769.015% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | 19.278% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | 37.53% |
| CanBas Co., Ltd. | -1.26 Billion JPY | 44.709% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | 12.62% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -106.831% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | 42.101% |
| Kidswell Bio Corporation | -1.33 Billion JPY | 47.755% |
| PeptiDream Inc. | 6.77 Billion JPY | 110.302% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 63.846% |
| Ribomic Inc. | -1.11 Billion JPY | 37.486% |
| SanBio Company Limited | -4.53 Billion JPY | 84.627% |
| Healios K.K. | -3.37 Billion JPY | 79.35% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | 39.591% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | 49.927% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | 50.265% |
| StemRIM | -2.07 Billion JPY | 66.388% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 157.125% |
| FunPep Company Limited | -994 Million JPY | 29.801% |
| Kringle Pharma, Inc. | -888.76 Million JPY | 21.489% |
| Stella Pharma Corporation | -760.3 Million JPY | 8.224% |
| TMS Co., Ltd. | -943.25 Million JPY | 26.025% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | 10.01% |
| Cuorips Inc. | -588.48 Million JPY | -18.571% |
| K Pharma,Inc. | 366.05 Million JPY | 290.619% |
| Takara Bio Inc. | 3 Billion JPY | 123.236% |
| ReproCELL Incorporated | -409.29 Million JPY | -70.483% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 6407.295% |
| StemCell Institute Inc. | 413.75 Million JPY | 268.643% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 582.867% |